Pune, India · Founded 2016 · Privately Held (backing)
Developer of novel drugs designed to treat the early stages of Vitiligo. Ahammune is based in Pune, India and was founded in 2016. Its last known valuation is $24.4 million. It has raised $7.2 million.
Last price · $/share
—
Implied valuation
$24.4M
Total raised
$7.2M
Last round
—
Cap table — not yet on record
Ahammune's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ahammune with a free account
·The complete investor list: 17 names
·Watch Ahammune: the Monday email on marks, rounds and moves
